Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chinese Hemodialysis Producer Signs Global Manufacturing Agreement

This article was originally published in PharmAsia News

Executive Summary

China's largest hemodialysis consumables producer Bain Medical Equipment (Guangzhou) has signed a global manufacturing agreement with the world's second largest artificial kidney manufacturer, Japan Asahi Kasei Kuraray Medical. Under the $10 million deal, Bain will provide loop dialysis catheter and puncture needles to the latter. Besides greater profits, Bain believes it will benefit even more from the management experience of the Japanese partner. Medical device manufacturing deals are not easily modified once signed since clinical trials and registration can take as long as two years. Moreover, few domestic enterprises produce moderate- and high-end products for global medical device makers, so the local firm's own brands will also become more internationally competitive. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069363

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel